ReviewFrontiers in neurology2025
Research progress on risk factors of recurrence of benign paroxysmal positional vertigo.
Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Construction of a recurrence risk prediction model for benign paroxysmal positional vertigo.Acta neurologica Belgica · 2026Article
- Association between serum 25-hydroxyvitamin D levels and prognosis in benign paroxysmal positional vertigo.Frontiers in nutrition · 2026Article
- Recurrence of benign paroxysmal positional vertigo: risk factors and outcomes.Revista da Associacao Medica Brasileira (1992) · 2026Article
- Association between systemic inflammatory markers and recurrence risk in benign paroxysmal positional vertigo: a retrospective cohort study.Acta biochimica Polonica · 2026Article
- Osteoporosis correlates with abnormal ocular vestibular evoked myogenic potential in patients with benign paroxysmal positional vertigo.Frontiers in neurologyArticle
- Development and external validation of a LASSO-based parsimonious nomogram for predicting BPPV recurrence: a multi-center retrospective cohort study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign paroxysmal positional vertigo (BPPV) is a prevalent disorder affecting the peripheral vestibular system. Although repositioning maneuvers can effectively alleviate symptoms in the majority of patients, the recurrence rate remains notably high, which has a significant impact on the quality of life of affected individuals. Consequently, it is essential to investigate the factors that contribute to the recurrence of BPPV. Current studies suggest that BPPV recurrence is associated with an array of factors, including metabolic abnormalities, endocrine disorders, vascular-metabolic diseases, prior head trauma, as well as gender and age-related factors. Further, vestibular dysfunction, genetic predispositions, and immunological factors also play a role. This paper aims to provide a comprehensive analysis of the mechanisms by which these factors influence BPPV recurrence. By synthesizing the most recent clinical research and meta-analyses, this study elucidates the clinical significance of BPPV. It also addresses relevant prevention and intervention strategies to equip clinicians to offer effective treatments and enhance long-term outcomes for patients experiencing BPPV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.